Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Primrose Bio Announces Investment from 1315 Capital to Advance Manufacturing Solutions for Next-Generation Therapeutics

Tuesday, June 18, 2024

Primrose Bio Inc a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in therapeutics and vaccines announced a significant equity investment

Mozart Therapeutics Doses First Cohort of Participants in Phase 1a/b Clinical Trial of MTX-101, in Development for Treatment of Autoimmune Diseases

Tuesday, June 18, 2024

Mozart Therapeutics a clinical stage biopharmaceutical company focused on the development of CD Treg modulators in autoimmune diseases today announce the dosing of the first cohort of participants

Zuellig Pharma launches innovative B2B e-commerce healthcare purchasing platform, eZRx+, to better serve pharmacies and clinics in Asia

Tuesday, June 18, 2024

Zuellig Pharma a leading healthcare solutions company in Asia has announced that it has launched eZRx an enhanced version of its premier selfservice BB eCommerce healthcare purchasing platform

VaxCell-Bio secures KDDF funding to develop solid tumor dual-target CAR-T therapy

Monday, June 17, 2024

VaxCellBio a pharmaceutical firm developing anticancer therapy products in Korea said it signed an agreement with the Korea Drug Development Fund last Friday to receive funding for the RD

LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial

Saturday, June 15, 2024

LIXTE Biotechnology Holdings Inc a clinical stage pharmaceutical company today announced a collaboration with Roche and the Netherlands Cancer Institute

Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine

Saturday, June 15, 2024

Novavax Inc a global company advancing proteinbased vaccines with its MatrixM adjuvant today announced that it has submitted an amendment to its Emergency Use Authorization

Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom

Friday, June 14, 2024

CPHI PMEC China June st returns to the Shanghai New International Expo Center amid soaring demand across the pharmaceutical supply chain in Asia China already the primary source of pharmaceutical ingredients and starting materials globally

Ethypharm Expands Its Mesalazine (Etiasa®) Portfolio in China

Friday, June 14, 2024

Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate Shanghai Ethypharm Pharmaceuticals Ltd from the Chinese Company Jiangsu Anbison Pharmaceutical Leader in essential medicines for central ner...

Viz.ai Collaborates with Hypertrophic Cardiomyopathy Association to Improve Care for Hypertrophic Cardiomyopathy Patients

Friday, June 14, 2024

Vizai the leader in AIpowered disease detection and intelligent care coordination today announced a collaboration with the Hypertrophic Cardiomyopathy Association the preeminent organization

SKAN Research Trust and Quadram Institute Bioscience to Develop Novel Microbial Therapies

Friday, June 14, 2024

SKAN Research Trust promoted by Indian entrepreneur Mr Ashok Soota and UKbased Quadram Institute Bioscience today announced that they will apply the cutting

magazine-slider-image
magazine-slider-image
Cytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024